Biomarkers in systemic lupus erythematosus - II. Markers of disease activity

被引:118
作者
Illei, GG [1 ]
Tackey, E [1 ]
Lapteva, L [1 ]
Lipsky, PE [1 ]
机构
[1] NIAMSD, NIH, DHHS, Bethesda, MD 20892 USA
来源
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 07期
关键词
D O I
10.1002/art.20345
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:2048 / 2065
页数:18
相关论文
共 179 条
[41]  
Dejica D, 2001, Roum Arch Microbiol Immunol, V60, P183
[42]   Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production [J].
DesaiMehta, A ;
Lu, LJ ;
RamseyGoldman, R ;
Datta, SK .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (09) :2063-2073
[43]   Peripheral blood lymphocytes in SLE - Hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells [J].
Devi, BS ;
Van Noordin, S ;
Krausz, T ;
Davies, KA .
JOURNAL OF AUTOIMMUNITY, 1998, 11 (05) :471-475
[44]   Mechanism of BLyS action in B cell immunity [J].
Do, RKG ;
Chen-Kiang, S .
CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (01) :19-25
[45]  
Ebo D., 1994, In Vivo (Attiki), V8, P577
[46]   Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus [J].
Egerer, K ;
Feist, E ;
Rohr, U ;
Pruss, A ;
Burmester, GR ;
Dörner, T .
LUPUS, 2000, 9 (08) :614-621
[47]  
Esdaile JM, 1996, J RHEUMATOL, V23, P1891
[48]   Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus - Why some tests fail [J].
Esdaile, JM ;
Abrahamowicz, M ;
Joseph, L ;
MacKenzie, T ;
Li, Y ;
Danoff, D .
ARTHRITIS AND RHEUMATISM, 1996, 39 (03) :370-378
[49]  
Ferriman EL, 2000, PRENATAL DIAG, V20, P851, DOI 10.1002/1097-0223(200010)20:10<851::AID-PD932>3.0.CO
[50]  
2-L